Home/Investors/Information not widely publicized

Information not widely publicized

Biotech Investor · 56 portfolio companies

Portfolio
56
Focus Areas
26
Top Stage
preclinical

Portfolio Companies

CompanyValuation
SynthioLabs
Exin Therapeutics
Delineate
Frekil
Bramante Biologics
Cytocast
Seamless Therapeutics
Phagos
GeneThera AI
DiogenX
ImmunoDx AI
Vector BioPharma
MediVax AI
Shenzhen TargetRx
TheraGen AI
MindRank
NeuShen Therapeutics
Neukio Biotherapeutics
NAYO Biotechnology
Miracogen
Membrane Solutions
Birdotech
Bioperfectus
Bioengine
Neuboron Medical Group
Nanjing Hanxin Pharmaceutical Technology
LEADS BioLabs
Imviva Biotech
ChomiX Biotech
Protelight Pharmaceuticals
Laviana Pharma
Qingfeng Pharmaceutical
HKeyBio
BioDlink
Ustar Biotechnologies
HWLAB
Immunowake
Huarong Pharm
Highlightll Pharmaceutical
DIAGENS
Dac Biotech
Chance Pharmaceuticals
GeneVax
Expedition Therapeutics
Syremis Therapeutics
Biospes
WestGene
Sichuan PriMed Shines Bio-tech
Ucello Therapeutics
TechnoDerma Medicines
AVE Science & Technology
Bio Genuine Biotech
Bellen Chemistry
Beijing Strong Biotechnologies
Beijing Diagreat Biotechnology
Beijing Challen Biotechnology